Viking Therapeutics (VKTX) Misses Q2 EPS by 13c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Stria Lithium rebrands as Arc Mineral Royalties after gold deal
• Marriott Vacations Worldwide (VAC) Declares $0.80 Quarterly Dividend; 3.2% Yield